newsfilter
← Latest News
GlobeNewswire·

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

  • Intellia Therapeutics, Inc. (NASDAQ: NTLA) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026, at 9:00 a.m. PT.
  • A live webcast of the presentation will be accessible on the Events and Presentations page within the Investors & Media section of www.intelliatx.com.
  • A replay of the webcast will remain available on Intellia's website for approximately 30 days.
  • Intellia is a clinical-stage gene editing company focused on developing CRISPR-based therapies to address unmet medical needs.
  • Jason Fredette serves as Vice President, Investor Relations and Corporate Communications for investor inquiries, while Matt Crenson of Ten Bridge Communications handles media inquiries.